Donna Ryan, MD, highlights how the media has helped to reframe obesity as a chronic disease and how antiobesity drugs are transforming metabolic disease treatment.
Donna H. Ryan, MD
Advertisement
Donna H. Ryan, MD, is professor emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, and past president of The Obesity Society.
Articles by Donna H. Ryan, MD
When asked about her 3 wishes for the future of obesity care, Donna Ryan, MD, told Patient Care that she had just one: access.
Donna Ryan, MD, discusses the most significant clinical trials published this year in the field of obesity medicine.
Donna Ryan, MD, highlights exciting advancements in weight loss and metabolic treatments, particularly involving GLP-1 RAs and related therapies.
The future of obesity medicine is filled with promise as GLP-1 RAs and other peptides continue to demonstrate pluripotency in metabolic disease.
Advertisement
Latest Updated Articles
Emerging Obesity Research to Watch For in 2025January 3rd 2025
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Issues Complete Response Letter for Cingulate ADHD Drug CTx-1301
2
FDA Approves Xocova as First Oral COVID-19 Postexposure Prophylaxis Option
3
Pediatric Influenza Vaccination Linked to Fewer Diagnoses in Claims Study
4
Transdermal Hormone Therapy for VMS and Cardiovascular Risk Management
5